Far-UVC light dramatically reduced airborne virus levels in a room where people were working, in the first study of the new air disinfection technology outside of an experimental setting.
Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?
The most socially disadvantaged communities in NYC used the subway to a greater degree during the pandemic, and the strongest driver of subway use was the percentage of essential workers.
Kidney complications were more common in New York City COVID-19 patients than in COVID-19 patients from other regions, a new single-center study from Columbia researchers has found.
A researcher at Columbia is studying ways to improve resilience among front-line clinicians who are feeling the emotional and physical impact of the COVID-19 pandemic.
Accompanied by boisterous cheers, Columbia surgeon Tomoaki Kato, MD, left NewYork-Presbyterian Hospital today after two months of treatment for COVID-19.
By arranging video calls and attending rounds, members of the departments of anesthesiology, radiology, and surgery help families stay connected with hospitalized COVID-19 patients.
Delays in reimplementing social distancing could result in a stronger rebound of COVID-19 infections and deaths, according to an analysis by Mailman researchers.
Lowering testosterone may prevent the new coronavirus from entering lung cells and lessen COVID-19 severity, new Columbia University research suggests. A trial has now begun in three VA hospitals.
Reports that highlight the disparate impact of COVID-19 in communities of color should pay more attention to factors that give rise to those outcomes, Mailman researchers say.
Columbia University's new "COVID-19 Trial Finder" is a simplified method for patients, clinicians, and healthy volunteers to find appropriate COVID clinical trials near their home.